The Lab21 facility in Cambridge is situated on the Trinity Science Park just north of the city centre. It consists of approximately 2000 m2 (20,000 sq ft) of office and high quality laboratories which include Category 2 and Category 3 containment suites. The laboratories are fully air handled and temperature controlled in order to provide the highest level of quality and performance.

The main activities for this site are:

• Corporate head office
• Laboratories for the provision of clinical testing services
• Research and development
• and shortly, our new GMP reagent production facility for diagnostic products

Our Newmarket facility is primarily focused on the production and distribution of Diagnostic Products and is situated just north of the town. It consists  of approximately 1200 m2 of offices, production laboratories, product finishing and warehousing. The facility is fully compliant with ISO9001 and ISO13485 (for further detail see our Quality page)

The Lab21 Bridport facility is again primarily concerned with the production and distribution of Diagnostic Products. It consists  of approximately 1000 m2 of offices, production laboratories, product finishing and warehousing. This facility is fully compliant with ISO9001 and ISO13485 (for further detail see our Quality page)

Lab21 acquired the Camberley facility through the acquisition of Microgen Bioproducts in 2010 and is located west of the town, close to the M3 motorway. With the site comprising offices, production laboratories, product finishing and warehousing, the primary function is production and distribution Microgen branded diagnostic products. The facility operates a quality management system compliant with ISO9001, ISO13485 and EN46001.

Lab21 Inc is the US subsidiary for Lab21 Ltd, formed following the acquisition of Selah Technologies in December 2009. Our US headquarters and newly constructed laboratory are located in the NEXT center on the banks of the Reedy River in downtown Greenville, South Carolina.

Leveraging the best practices of our acclaimed diagnostic service laboratories in the UK, our new 7,500 ft² CLIA laboratory (#42D2027903) is designed and equipped to provide advanced diagnostic services with a focus on enabling personalized medicine for oncology and virology including sequencing and HPLC/mass spec.